Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRNX Crinetics Pharmaceuticals Inc.

盘后交易 07-31 17:23:56 EDT

83.52

-0.11

-0.13%

盘后83.47

-0.05-0.06%

17:11 EDT

最高83.80	最低83.47	成交量186.11万
今开83.75	昨收83.63	日振幅0.39%
总市值88.06亿	流通市值79.80亿	总股本1.05亿
成交额1.56亿	换手率1.95%	流通股本9,554万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":83.52,"timestamp":1785528000000,"preClose":83.63,"halted":0,"volume":1861138,"hourTrading":{"tag":"盘后","latestPrice":83.47,"preClose":83.52,"latestTime":"17:11 EDT","volume":45254,"amount":3779704.13546,"timestamp":1785532267080,"change":-0.05,"changeRate":-0.000599,"amplitude":0.001557},"delay":0,"changeRate":-0.0013153174698074786,"floatShares":95543500,"shares":105439535,"eps":-5.129138,"marketStatus":"盘后交易","change":-0.11,"latestTime":"07-31 17:23:56 EDT","open":83.75,"high":83.8,"low":83.47,"amount":155736052.449232,"amplitude":0.003946,"askPrice":83.98,"askSize":1,"bidPrice":83.47,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-5.129138,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785542400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1531886400000,"exchange":"NASDAQ","adjPreClose":83.63,"preHourTrading":{"tag":"盘前","latestPrice":83.75,"preClose":83.63,"latestTime":"09:29 EDT","volume":45773,"amount":3829572.86985,"timestamp":1785504599999,"change":0.12,"changeRate":0.001435,"amplitude":0.003304},"postHourTrading":{"tag":"盘后","latestPrice":83.47,"preClose":83.52,"latestTime":"17:11 EDT","volume":45254,"amount":3779704.13546,"timestamp":1785532267080,"change":-0.05,"changeRate":-0.000599,"amplitude":0.001557},"volumeRatio":0.683786,"impliedVol":0.1869,"impliedVolPercentile":0.0558},"requestUrl":"/m/hq/s/CRNX","defaultTab":"news","newsList":[{"id":"1189313061","title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计翻倍增长，机构观点偏积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1189313061","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189313061?lang=zh_cn&edition=full","pubTime":"2026-07-29 00:25","pubTimestamp":1785255911,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.将于2026年08月04日发布财报，市场聚焦新药商业化进展与费用节奏对利润的影响。一致预期显示，本季度公司营收预计为1,484.01万美元，同比增长113.89%；调整后每股收益预计为-1.21美元，同比改善10.07%；息税前利润预计为-1.36亿美元，同比改善20.45%。由于预测未给出毛利率与净利润或净利率的具体值，相关指标不予展示。产品板块在上季度占比达到96.01%，预计本季度营收增长的主要驱动力仍来自产品收入的放量。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计翻倍增长，机构观点偏积极","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116538455","title":"财报前瞻｜Crinetics Pharmaceuticals Inc.机构偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1116538455","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116538455?lang=zh_cn&edition=full","pubTime":"2026-07-28 11:30","pubTimestamp":1785209438,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.将于2026年08月04日美股盘后发布财报，市场聚焦核心管线商业化放量与收购进展对费用和盈利路径的影响。公司收入结构以产品销售为主，上季度“产品”收入为1,030.60万美元，占比96.01%，显示核心商业化产品对现金流与规模化收入的带动作用。发展前景中体量最大的现有业务仍来自核心口服内分泌产品条线，上季度相关产品收入1,030.60万美元，在带动公司整体营收同比+2873.41%中贡献最为明显。从近期覆盖机构的表态看，偏谨慎的观点占优。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百亿美元收购罕见病药企 拓宽内分泌管线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651117599?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals  与 Crinetics Pharmaceuticals  共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ9MQY76.HKD","LU0566484027.USD","LU0757428866.USD","LU1585245621.USD","LU2362541273.HKD","BK4585","LU1674673428.USD","LU0109394709.USD","LU0079474960.USD","LU1035775433.USD","BIB","LU2417539215.USD","IE00B4R5TH58.HKD","SG9999001176.USD","BK4532","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IBB","SG9999013999.USD","LU2462157665.USD","LU0889565916.HKD","LU0432979614.USD","IE00B19Z9Z06.USD","LU1093756325.SGD","IE00B19Z3581.USD","LU2362541513.USD","LU2237438978.USD","VERX","LU0256863811.USD","LU2362540622.SGD","VRTX","BK4588","LU0061475181.USD","PBE","LU2456880835.USD","IBBQ","IE0002270589.USD","CRNX","IE0002141913.USD","LU1778281490.HKD","LU1069344957.HKD","IDNA","LU0234570918.USD","IE00BJT1NW94.SGD","LU1093756168.USD","IE00B894F039.SGD","BK4007","SG9999001176.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161465425","title":"暴涨近99%！Crinetics获福泰制药拟100亿美元现金收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1161465425","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161465425?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:52","pubTimestamp":1783432357,"startTime":"0","endTime":"0","summary":"7月7日，Crinetics美股盘中大幅上涨，涨近99%。消息面上，福泰制药同意以约100亿美元现金收购Crinetics，每股收购价为85美元，较Crinetics周一收盘价溢价约102%。受交易影响，福泰制药股价跌超2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ce70f982c0b1f1a2ba3407f02bcf893f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187410524","title":"异动解读｜Crinetics Pharmaceuticals盘中上涨98.85%，福泰制药拟斥资100亿美元溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1187410524","media":"行情直击","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187410524?lang=zh_cn&edition=full","pubTime":"2026-07-07 21:35","pubTimestamp":1783431342,"startTime":"0","endTime":"0","summary":"7月7日，Crinetics Pharmaceuticals盘中上涨98.85%，报83.5美元/股，成交额28.32亿美元。消息面上，福泰制药宣布将以每股85美元现金收购Crinetics，交易总股权价值约100亿美元，较收购前股价溢价近100%。福泰制药预计此次收购将为其带来约50亿美元峰值销售机会，并于2029年对非GAAP运营收入产生积极贡献。收购消息公布后，Piper Sandler及Cantor Fitzgerald均将Crinetics评级下调至中性，目标价调整至85美元，与收购报价一致。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1156298608","title":"Piper Sandler下调Crinetics评级至中性，目标价降至85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156298608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156298608?lang=zh_cn&edition=full","pubTime":"2026-07-07 20:27","pubTimestamp":1783427261,"startTime":"0","endTime":"0","summary":"投资机构Piper Sandler调整了对Crinetics Pharmaceuticals Inc. (CRNX) 的投资评级，将其从“增持”下调至“中性”。与此同时，该机构也大幅调降了该公司的目标股价，从原先的97美元降至85美元。这一调整反映了分析师对该公司近期前景的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CRNX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134104489","title":"盘前异动 | 存储股集体回调，美光科技、西部数据跌近5%，中概股多数走低","url":"https://stock-news.laohu8.com/highlight/detail?id=1134104489","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134104489?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:02","pubTimestamp":1783411365,"startTime":"0","endTime":"0","summary":"7月7日，美股三大股指期货盘前表现分化，道指期货升近0.2%，标普500指数期货跌近0.2%，纳指期货跌超0.8%。盘面上，大型科技股小幅上涨，微软涨超0.6%，亚马逊、Meta小幅走高；存储概念股盘前集体下跌，美光科技、西部数据跌近5%，闪迪跌超4%，希捷科技跌超3%；热门中概股多数走低，京东、拼多多跌近1%，百度跌近2%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIDG","AAPB","MVLL","LINT","FBYY","AMDG","KBDU","NVDX","SNDC","INTW","NVDS","AMDD","MUD","AAPY","META","AAPW","KPDD","MSFL","NVDO","PDD","NVD","BBYY","NVII","PDDL","NVDW","MSFT","NVDG","WDCX","AMD","NVDU","MU","NVDY","AMDW","07788","AMZW","AAPX","ANV","BABA","MSFO","AMUU","INTC","AMZU","AAPL","JD","AMZZ","AMDU","AMZY","KJD","METD","MSFX","AMZD","BABW","BIDU","NVDB","FBY","SNDU","NTES","SNDQ","STX","BABO","NVDL","WDC","AMDL","AMDY","MULL","AAPU","AAPD","CRNX","MSFD","SNDK","SNXX","07388","BABU","MSFY","NVDA","AMYY","AMZP","NVDD","KBAB","FBL","NVDQ","METW","MSFU","SNDG","MRVL","MRVU","DIPS","MSFW","APLY","METU","NVYY","AMZN","DAMD","BABX","AZYY","MUU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649708736","title":"100亿美元砸出史上最大收购：福泰制药(VRTX.US)溢价100%收购Crinetics(CRNX.US)，杀入内分泌赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2649708736","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649708736?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:35","pubTimestamp":1783384535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","IE00BJT1NW94.SGD","LU0234570918.USD","IBBQ","IBB","IE00B19Z9Z06.USD","LU0289739699.SGD","SGXZ57979304.SGD","SG9999001176.SGD","IE00B19Z9P08.USD","BBH","LU0256863811.USD","LU2362540622.SGD","VRTX","BK4585","LU2324357040.USD","CRNX","LU0109394709.USD","IE0002270589.USD","LU0417517546.SGD","LU1585245621.USD","LU0320765992.SGD","LU1430594728.SGD","LU1674673691.USD","BIB","IE00B19Z3581.USD","LU0061475181.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1093756168.USD","LU2417539215.USD","IDNA","LU1778281490.HKD","BK4139","LU0058720904.USD","LU0432979614.USD","LU2237438978.USD","SG9999001176.USD","LU0079474960.USD","PBE","LU0823416689.USD","LU2456880835.USD","BK4588","LU1093756325.SGD","LU1035775433.USD","LU2362541273.HKD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188431917","title":"美股夜盘｜存储概念股普跌，美光科技、闪迪跌超2%；Crinetics涨超100%、费哲金融服务涨6%、Rivian跌近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188431917","media":"美股夜盘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188431917?lang=zh_cn&edition=full","pubTime":"2026-07-07 08:06","pubTimestamp":1783382813,"startTime":"0","endTime":"0","summary":"费哲金融服务涨6.2%，《华尔街日报》称多家大型银行探讨收购其旗下支付网络，或为绕开借记卡手续费上限。SpaceX跌1.75%，社交媒体讨论称其股票面临破发压力。Rivian Automotive, Inc.  跌8.99%，宣布增发7500万股以履行美国能源部贷款相关出资，并公布二季度营收预期，且拟授予承销商30天超额配售权，稀释担忧压制股价。存储芯片股下跌，Roundhill Memory ETF跌2.75%，闪迪跌2.55%，美光科技跌2.31%，西部数据跌1.93%，希捷科技跌1.18%。其中，美光科技受高管减持消息影响。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e2482c489456454bb2227ec34bbeb7d8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2048586759.USD","LU2290526834.HKD","FINX","DRAM","LU2250418816.HKD","LU1868837136.USD","LU0889565833.HKD","BK4141","SNDC","LU2471134796.USD","IETC","LU0081259029.USD","QQQG","LU0208291251.USD","LU0274383776.USD","LU2168564065.EUR","LU2750360997.AUD","LU1823568750.SGD","MULL","BK4170","LU2102340556.USD","FISV","LU2168563687.JPY","LU0719512351.SGD","LU1201861165.SGD","SNXX","BAI","EGGY","LU1201861249.SGD","LU0054578231.USD","VGT","LU0203345920.USD","IE00B1XK9C88.USD","BK4575","LU1316542783.SGD","LU0963586101.USD","XNTK","LU0130103400.USD","CGGO","LU1861220207.SGD","COWG","FSMD","SCHM","IE00B19Z3B42.SGD","LU2286300806.USD","JGRO","IDRV","LU2360107168.USD","CNAV","RULE","SNDK","LU2360106780.USD","BK4579","MUD","LU1989764664.SGD","CHPS","DRAL","LU2543165471.USD","RAM","LU0792757196.USD","EFIV","LU2357627491.SGD","PTF","LU0859254822.USD","GB00BDT5M118.USD","LU1989764748.USD","LU2211815571.USD","SOXX","LU0157215616.USD","RIVN","LU0056508442.USD","LU0070302665.USD","BK4227","MUU","BK4555","SOXQ","LU1923622291.USD","LU0648000940.SGD","LU2168564222.USD","LU1803068979.SGD","LU0154236417.USD","LU0130102774.USD","LU0082616367.USD","BK4106","LU2168564149.EUR","LU1861220033.SGD","FTXL","LU2458330243.SGD","IE00BJLML261.HKD","FTEC","AIFD","LU2458330169.SGD","SG9999001424.SGD","FCUS","LU1868836757.USD","LU2471134523.USD","LU0980610538.SGD","BK4605","LU2750360641.GBP","SNDG","IXN","BK4566","CHAT","SCHA","LU1852331112.SGD","IE0002270589.USD","LU0889566641.SGD","BK4596","AIQ","LU1323610961.USD","LU2089985449.USD","TMSL","BK4588","FDRV","LU0203347892.USD","MU","WLDR","BK4527","LU0061475181.USD","SNDQ","BK4543","BK4512","LU0354030438.USD","LU0683600562.USD","SHOC","LU0109392836.USD","LU2125909759.SGD","AIS","IE00BWXC8680.SGD","LU2471134952.CNY","IE00BKDWB100.SGD","LU1914381329.SGD","LU2471134879.HKD","LU1366333091.USD","LU0238689110.USD","LU1868836591.USD","OPTZ","SMH","BK4099","EMSF","ARTY","FDTX","LU0648001328.SGD","LU2125909916.SGD","LU0096364046.USD","LU1046421795.USD","IE0034235303.USD","PSI","LU2054465674.USD","LU0320765489.SGD","IE0009356076.USD","LU0354030511.USD","FXL","LU0127658192.USD","IE000M9KFDE8.USD","LU1868836914.USD","BK4547","SNDU","LU0787776722.HKD","BK4553","LU2168564495.EUR","XLK","WUGI","CRNX","FAI","BK4532","LU1267930813.SGD","BK4554","IE00B19Z3581.USD","LU1861217088.USD","BK4533","USXF","RVNL","LEGR","IE00B5949003.HKD","LU2931357623.SGD","IE00BK4W5L77.USD","BK4585","IE00B7SZLL34.SGD","TRFK","IE00BK4W5M84.HKD","LU1868837300.USD","LU0642271901.SGD","LU1861215975.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1198601451","title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1198601451","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198601451?lang=zh_cn&edition=full","pubTime":"2026-07-07 06:13","pubTimestamp":1783376037,"startTime":"0","endTime":"0","summary":"7月7日，Vertex制药公司周一宣布，将以每股$85.00的现金价格收购Crinetics制药公司，交易总股权价值约为100亿美元，扣除预计所获现金后净值约为88亿美元。消息公布后，Crinetics盘后股价飙升近100%。两家公司董事会均已一致批准此次交易。交易预计于2026年第三季度完成，尚需满足惯常交割条件，包括获得监管机构批准及Crinetics股东批准。Crinetics旗下产品PALSONIFY已于2025年9月获得美国食品药品监督管理局批准，近期亦获欧洲药品管理局批准上市。","market":"us","thumbnail":"https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e68f18a297e419bae3cc0320b6d8ff4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"福泰制药拟斥资100亿美元收购Crinetics制药公司","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159544198","title":"SEC文件披露：特定情况下交易终止，Crinetics Pharmaceuticals或需向福泰制药支付3.5047亿美元解约费","url":"https://stock-news.laohu8.com/highlight/detail?id=1159544198","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159544198?lang=zh_cn&edition=full","pubTime":"2026-07-07 05:22","pubTimestamp":1783372928,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件披露，Crinetics Pharmaceuticals Inc. 与福泰制药之间的交易若在特定情况下被终止，前者可能需要向后者支付高达3.5047亿美元的终止费用。该文件明确了触发这一巨额财务义务的具体情形。协议条款显示，这笔费用的支付并非自动生效，而是与特定的终止条件紧密挂钩。然而，这也同时意味着，一旦协议因规定情形破裂，Crinetics Pharmaceuticals将面临显著的财务支出。目前，市场正密切关注两家公司后续的动向以及该交易的具体进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BK4588","SG9999001176.SGD","LU1430594728.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","LU1035775433.USD","LU1069344957.HKD","LU1585245621.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU0256863811.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU0058720904.USD","LU0320765992.SGD","LU0432979614.USD","LU2362540622.SGD","IE00B894F039.SGD","BK4007","BK4567","IBB","IE00B19Z9P08.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU2237438978.USD","BK4585","LU2324357040.USD","LU0109394709.USD","IE00B19Z3581.USD","SG9999001176.USD","CRNX","LU1674673428.USD","LU2417539215.USD","IE00B2B36J28.USD","LU2362541513.USD","LU0234570918.USD","VRTX","BBH","LU1674673691.USD","LU0289739699.SGD","LU2456880835.USD","IE00B19Z3B42.SGD","IDNA","IBBQ","LU0417517546.SGD","LU1778281490.HKD","IE00BFTCPJ56.SGD","IE0002270589.USD","BK4532","BK4139","LU0889565916.HKD","IE00BZ9MQY76.HKD","LU1093756168.USD","BIB","LU1093756325.SGD","LU2362541273.HKD","LU2236285917.USD","PBE","LU0823416689.USD","LU0079474960.USD","LU2462157665.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833937","title":"Crinetics与福泰制药交易预计2029年提升后者非GAAP运营收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127833937?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:07","pubTimestamp":1783368452,"startTime":"0","endTime":"0","summary":"根据最新披露的财务预测，Crinetics Pharmaceuticals Inc. 与福泰制药达成的战略合作，预计将在2029年对福泰制药的非通用会计准则运营收入产生积极贡献。\n此次交易的结构设计旨在通过长期协同效应，增强福泰制药的盈利质量。分析指出，该合作不仅将拓展福泰制药在特定治疗领域的产品管线，还可能优化其整体运营效率。市场预期，随着合作项目进入成熟阶段，其对财务指标的正面影响将逐步显现。\n财务模型显示，此次合作带来的收入增长与成本协同效应，是推动非通用会计准则运营收入提升的关键因素。投资者正密切关注交易细节及后续整合进程，以评估其长期价值创造潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU0079474960.USD","IDNA","VRTX","LU0823416689.USD","LU1069344957.HKD","LU0058720904.USD","LU1093756168.USD","LU0289739699.SGD","LU0320765992.SGD","LU2456880835.USD","IE00B19Z9Z06.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU1674673691.USD","SG9999001176.SGD","LU1585245621.USD","IE00B894F039.SGD","LU0256863811.USD","IBB","LU2462157665.USD","BBH","BK4567","LU0234570918.USD","LU0061475181.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1778281490.HKD","LU0417517546.SGD","LU2236285917.USD","BK4007","LU2362540622.SGD","LU2362541513.USD","SG9999001176.USD","LU0432979614.USD","IE0009355771.USD","BK4585","BIB","LU2237438978.USD","LU2417539215.USD","BK4533","LU1430594728.SGD","LU2362541273.HKD","SG9999013999.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","IE0002141913.USD","LU2324357040.USD","BK4588","BK4139","BK4532","IE00B19Z3581.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","LU1674673428.USD","LU0889565916.HKD","PBE","IE00BJJMRZ35.SGD","CRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179291339","title":"Crinetics Pharmaceuticals：融资获美国银行与摩根士丹利的45亿美元全额承诺过桥贷款支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1179291339","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179291339?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:06","pubTimestamp":1783368378,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 的融资计划，已获得来自美国银行和摩根士丹利高级融资部门提供的总额高达45亿美元的全额承诺过桥贷款支持。这笔资金将为公司的战略推进提供坚实的财务后盾。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ57979304.SGD","LU0079474960.USD","IDNA","VRTX","LU0823416689.USD","LU1069344957.HKD","LU0058720904.USD","LU1093756168.USD","LU0289739699.SGD","LU0320765992.SGD","LU2456880835.USD","IE00B19Z9Z06.USD","LU1093756325.SGD","IE00B4R5TH58.HKD","IE0002270589.USD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU1674673691.USD","SG9999001176.SGD","LU1585245621.USD","IE00B894F039.SGD","LU0256863811.USD","IBB","LU2462157665.USD","BBH","BK4567","LU0234570918.USD","LU0061475181.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1778281490.HKD","LU0417517546.SGD","LU2236285917.USD","BK4007","LU2362540622.SGD","LU2362541513.USD","SG9999001176.USD","LU0432979614.USD","IE0009355771.USD","BK4585","BIB","LU2237438978.USD","LU2417539215.USD","BK4533","LU1430594728.SGD","LU2362541273.HKD","SG9999013999.USD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","IE0002141913.USD","LU2324357040.USD","BK4588","BK4139","BK4532","IE00B19Z3581.USD","LU1035775433.USD","IE00BFTCPJ56.SGD","LU1674673428.USD","LU0889565916.HKD","PBE","IE00BJJMRZ35.SGD","CRNX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117418128","title":"Crinetics公布Atumelnant治疗先天性肾上腺皮质增生症二期试验完整结果，并于Endo 2026进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1117418128","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117418128?lang=zh_cn&edition=full","pubTime":"2026-06-15 04:30","pubTimestamp":1781469015,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 在Endo 2026会议上，以口头报告形式公布了其药物Atumelnant用于治疗先天性肾上腺皮质增生症的二期临床试验完整数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101516072","title":"Crinetics Pharmaceuticals Inc. 预期2026年GAAP运营支出6-6.5亿美元；非GAAP运营支出4.8-5.2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1101516072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101516072?lang=zh_cn&edition=full","pubTime":"2026-05-08 04:29","pubTimestamp":1778185754,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc. 公布了其2026财年的财务指引。该公司预计，按照美国通用会计准则（GAAP）计算，其2026年的运营支出将在6亿美元至6.5亿美元之间。同时，根据非美国通用会计准则（Non-GAAP）测算，公司预期的运营支出范围则为4.8亿美元至5.2亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRNX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137985690","title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计增5.55倍，看多占优","url":"https://stock-news.laohu8.com/highlight/detail?id=1137985690","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137985690?lang=zh_cn&edition=full","pubTime":"2026-02-19 12:36","pubTimestamp":1771475790,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals Inc.将于2026年02月26日发布最新季度财报，市场关注收入恢复与费用节律对每股收益的影响以及年初融资带来的研发推进节奏。公司主营收入以“授权费”为核心，上季度该科目为45.80万美元，体量小但对总收入的贡献明确，未来变动仍取决于合作里程碑与进度。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Crinetics Pharmaceuticals Inc.本季度营收预计增5.55倍，看多占优","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517589074","title":"Crinetics Pharmaceuticals, Inc.2024财年实现净利润-2.98亿美元，同比减少38.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517589074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517589074?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363257,"startTime":"0","endTime":"0","summary":"3月8日，Crinetics Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-2.98亿美元，同比减少38.60%；其中营业收入为1.04百万美元，同比减少74.06%，每股基本收益为-3.69美元。从资产负债表来看，Crinetics Pharmaceuticals, Inc.总负债4.01亿美元，其中短期债务7.15百万美元，资产负债比为4.31，流动比率为0.24。机构评级：截至2025年3月8日，当前有14家机构对Crinetics Pharmaceuticals, Inc.目标价做出预测，其中目标均价为75.64美元，其中最低目标价为55.00美元，最高目标价为100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000248abed66f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514904376","title":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904376","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514904376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757319,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：维持Crinetics Pharmaceuticals(CRNX.US)评级，由优于大市调整至优于大市评级, 目标价由92.00美元调整至91.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28234148468148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171905954","title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1171905954","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171905954?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:22","pubTimestamp":1740756147,"startTime":"0","endTime":"0","summary":"Crinetics制药公司今日盘中大涨5.09%,引发了市场的广泛关注。\n公司日前公布的最新季度业绩显示,2024年第四季度,公司调整后每股亏损为88美分,同比收窄2美分,略好于分析师预期的89美分亏损。尽管如此,公司当季实际亏损8060万美元,同比加大。\n不过,公司当季度业绩整体表现略好于预期,以及分析师看好其长期前景,推动了公司股价今日盘中出现较大涨幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Crinetics制药盘中大涨5.09%,公司上一季度亏损收窄","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125291574","title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1125291574","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125291574?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:24","pubTimestamp":1740691484,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals  公布季度每股亏损 $，与分析师一致预期相符。这比去年同期每股亏损 $ 增加了 2.22%。以上内容来自Benzinga Earnings专栏，原文如下：Crinetics Pharmaceuticals  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 2.22 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Crinetics Pharmaceuticals 第四季度 GAAP 每股收益 $(0.88)，符合预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crinetics.com;ir.crinetics.com;investors.vrtx.com","stockEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":1.2349},{"period":"3month","weight":1.1433},{"period":"6month","weight":0.6746},{"period":"1year","weight":1.8611},{"period":"ytd","weight":0.7966}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.078473},{"month":2,"riseRate":0.5,"avgChangeRate":-0.021565},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056934},{"month":4,"riseRate":0.625,"avgChangeRate":0.06869},{"month":5,"riseRate":0.5,"avgChangeRate":-0.026047},{"month":6,"riseRate":0.625,"avgChangeRate":0.005036},{"month":7,"riseRate":0.5,"avgChangeRate":0.132083},{"month":8,"riseRate":0.5,"avgChangeRate":0.05546},{"month":9,"riseRate":0.375,"avgChangeRate":0.104829},{"month":10,"riseRate":0.5,"avgChangeRate":0.007484},{"month":11,"riseRate":0.875,"avgChangeRate":0.104868},{"month":12,"riseRate":0.75,"avgChangeRate":0.036899}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}